That convergence of independent findings across diverse research groups adds weight to the overall body of evidence in a way that designed peptides with narrower mechanistic rationales cannot replicate
FDA received another adverse event report on February 4, 2019, associated with an intravenous injection of a drug containing L-glutathione 200mg/mL compounded by a different pharmacy that also used L-glutathione repackaged by Letco (lot number: 1808030045, expiration date: 6/17/2020)
Clinical, Cosmetic and Investigational Dermatology , Volume 10 , 147153
FULL INGREDIENTS: Water,Glycerin,Caprylic/Capric Triglyceride,Polyglycerin-3,Butylene Glycol,1,2-Hexanediol,Niacinamide,Methylpropanediol,Diglycerin,Laminaria Japonica Extract,Eclipta Prostrata Leaf Extract,Hydrogenated Lecithin,Ammonium Acryloyldimethyltaurate/VP Copolymer,Dipropylene Glycol,Acrylates/C10-30 Alkyl Acrylate Crosspolymer,Glutathione,Tromethamine,Ethylhexylglycerin,Hydrolyzed Sponge,Fructooligosaccharides,Adenosine,Beta-Glucan,Glyceryl Polymethacrylate,Hydrolyzed Hyaluronic Acid,Calcium Silicate,Sodium Silicate,Tocopherol,3-O-Ethyl Ascorbic Acid,Tocopheryl Acetate
